ROCHE GS (ROG.SW) Financials
ROG.SW Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-12-31 | 90.5 billion | 57.2 billion |
| 2023-06-30 | 84.4 billion | 54.0 billion |
| 2023-03-31 | ? | ? |
| 2022-12-31 | 88.2 billion | 56.1 billion |
ROG.SW Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-12-31 | 5.2 billion | 447.0 million |
| 2023-06-30 | 5.6 billion | 383.0 million |
| 2023-03-31 | ? | ? |
| 2022-12-31 | 6.1 billion | 403.0 million |
ROG.SW Net Income
| Date | Net Income |
|---|---|
| 2023-12-31 | 4.4 billion |
| 2023-06-30 | 7.1 billion |
| 2023-03-31 | 3.6 billion |
| 2022-12-31 | 3.9 billion |
ROG.SW Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-12-31 | 10.5 billion | - | 1.6 billion |
| 2023-06-30 | 7.5 billion | 20.3 billion | - |
| 2023-03-31 | - | - | - |
| 2022-12-31 | 9.8 billion | 21.4 billion | 1.2 billion |
ROG.SW Shares Outstanding
ROG.SW Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-12-31 | 2.7 billion | 6.9 billion | - | - |
| 2023-06-30 | 2.0 billion | 6.3 billion | 6.5 billion | - |
| 2023-03-31 | 870.0 million | - | - | - |
| 2022-12-31 | 2.5 billion | 7.4 billion | 6.5 billion | - |
ROG.SW Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-12-31 | 28.9 billion | 8.3 billion |
| 2023-06-30 | 29.8 billion | 7.5 billion |
| 2023-03-31 | - | - |
| 2022-12-31 | 31.0 billion | 9.1 billion |
ROG.SW
Price: CHF221.20
Dividend Yield: 0.04%
Forward Dividend Yield: 4.34%
Payout Ratio: 67.09%
Dividend Per Share: 9.60 CHF
Earnings Per Share: 14.31 CHF
P/E Ratio: 15.88
Exchange: EBS
Sector: Healthcare
Industry: Drug Manufacturers - General
Volume: 1.1 million
Market Capitalization: 181.2 billion
Average Dividend Frequency: 1
Years Paying Dividends: 29
DGR3: 1.78%
DGR5: 2.66%
DGR10: 2.52%
DGR20: 8.36%